Industry Case Study | A First Experience with the ava® Electromechanical Injector and its Approach to Connected Health
Information
The ava e-Device aims to support patients, not just with their medication but with their disease as a whole. The e-Device has been developed based on patient feedback to minimise barriers to successful self-injection. The e-Device has evolved into ‘ava Connect’, an updated version of the device with new connectivity options and additional features.
The CimplyMe companion app further extends this support and can be used alongside the e-Device or with the other certolizumab pegol self-injection devices.
Providing a portfolio of self-injection devices allows patients to choose a device most suited to their individual needs, improving patient experience and increasing medication adherence
